Journal
CURRENT OPINION IN PHARMACOLOGY
Volume 13, Issue 4, Pages 632-640Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.coph.2013.05.012
Keywords
-
Categories
Funding
- National Institutes of Health [P01GM095467, R01GM38765]
Ask authors/readers for more resources
Lipid mediators are appreciated for their roles in leukocyte traffic required in host defense. With identification of novel resolution phase mediators, resolvins, protectins and maresins, these three families and their aspirin-triggered forms, given their potent stereoselective actions with human cells and animal disease models, are coined specialized pro-resolving mediators (SPM). Stereochemistries of key SPM are established and several groups reported organic synthesis. Given increased availability, this two-year-review period expands their potent pro-resolving and non-redundant actions. Collectively, they support the concept that return of acute inflammation involves active biosynthesis and SPM signaling toward homeostasis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available